tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
GMAB
Genmab
RESEARCH TOOLSreports
Want to see GMAB full AI Analyst Report?

Genmab (GMAB) Stock News & Sentiment

776 Followers
Genmab: Buy Rating Backed by Expanded Petosemtamab-Keytruda Phase III Trial and Blockbuster Late-Stage Pipeline
Premium
Ratings
Genmab: Buy Rating Backed by Expanded Petosemtamab-Keytruda Phase III Trial and Blockbuster Late-Stage Pipeline
5d ago
GMAB
Premium
Ratings
Genmab: Late‑Stage Pipeline De‑Risking and 2026 Catalysts Create Compelling 25% Upside Despite Darzalex LOE Overhang
10d ago
GMAB
Genmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
Premium
Company Announcements
Genmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
15d ago
6K
GMAB
Genmab Registers AGM-Approved Share Capital Reduction After Cancelling 1.9 Million Treasury Shares
Premium
Company Announcements
Genmab Registers AGM-Approved Share Capital Reduction After Cancelling 1.9 Million Treasury Shares
15d ago
6K
GMAB
Genmab Discloses Orbis as New 4.85% Major Shareholder
Premium
Company Announcements
Genmab Discloses Orbis as New 4.85% Major Shareholder
18d ago
6K
GMAB
Genmab Boosted by Strong Q1 2026 DARZALEX Sales of Nearly USD 4 Billion
Premium
Company Announcements
Genmab Boosted by Strong Q1 2026 DARZALEX Sales of Nearly USD 4 Billion
18d ago
6K
GMAB
Balancing Strong Near‑Term Execution With Long‑Term Patent and Pipeline Uncertainty at Genmab
Premium
Ratings
Balancing Strong Near‑Term Execution With Long‑Term Patent and Pipeline Uncertainty at Genmab
18d ago
GMAB
More GMAB News >

GMAB News on the Web

Genmab Updates Articles of Association to Expand Capital-Raising and Incentive Flexibility
TipRanks News
Neutral
Genmab Registers AGM-Approved Share Capital Reduction After Cancelling 1.9 Million Treasury Shares
TipRanks News
Neutral
Genmab Discloses Orbis as New 4.85% Major Shareholder
TipRanks News
Neutral
Genmab Boosted by Strong Q1 2026 DARZALEX Sales of Nearly USD 4 Billion
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Stryker (SYK) and Genmab (GMAB)
TipRanks News
Bullish
Genmab reports Darzalex Q1 worldwide sales $3.964B
TipRanks News
Bullish
Genmab’s DARZALEX Sales Hit $3.96 Billion in Q1 2026—Royalties Set for Significant Boost
Market Chameleon
Neutral
Balancing Strong Near‑Term Execution With Long‑Term Patent and Pipeline Uncertainty at Genmab
TipRanks News
Neutral

News Score - Last 7 Days

Positive
GMAB
Sector Average
Media Buzz
This Week8 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GMAB’s Media Buzz Sentiment?
8 articles about GMAB were published this week. In an average week, 4.25 articles are published.
    What is GMAB’s weekly average amount of articles?
    In an average week, 4.25 articles about GMAB are published.
      What is GMAB’s News Sentiment?
      100% of articles about GMAB were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week